Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Daratumumab, Bortezomib, Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory (RR) Multiple Myeloma (MM): Pooled Subgroup Analysis of Lepus and Castor

Blood (2020) 136 (Supplement 1): 38–41.

https://doi.org/10.1182/blood-2020-136108

Published: 2020

Journal Articles

Efficacy Analysis of Ruxolitinib in Treatment of 72 Patients with Myelofibrosis in a Chinese Institution

Yunfan Yang, MD, Zhongqing Zou, MD, Ting Liu, MD PhD, Yongqian Jia, PhD, Ting Niu, MD PhD, Huanling Zhu, MD, Yu Wu, MD, Yuping Gong, MD, Hong Chang, MD, Jie Ji, MD, Jian Li, MD, Ling Pan

Blood (2019) 134 (Supplement_1): 5384.

https://doi.org/10.1182/blood-2019-128553

Published: 2019

Journal Articles

A Novel Hybrid Transplantation with Autologous Hematopoietic Stem Cells and Matched Unrelated Cord Blood Stem Cells Is Effecttive and Safe for Relapsed or Refractory Lymphoma: A Pilot Study

Blood (2019) 134 (Supplement_1): 5713.

https://doi.org/10.1182/blood-2019-129459

Published: 2019

Journal Articles

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

Mengyao Wang, MD, Ying Qu, PhD, Zhiyong Qian, PhD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 4181.

https://doi.org/10.1182/blood-2018-99-119151

Published: 2018

Journal Articles

KMT2D Is a Haploinsufficient Tumor Suppressor in Acute Leukemia

Jing Xu, MD, Yu Liu, PhD, Chong Chen, PhD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 1511.

https://doi.org/10.1182/blood-2018-99-119038

Published: 2018

Journal Articles

Alox15b Gene Contributes to Lymphoma Tumorigenesis Via PI3K/AKT/mTOR Pathway Activation and Has a Synergistic Effect with Alox5 Gene

Pengpeng Liu, MD, Yu Liu, PhD, Chong Chen, PhD, Ting Liu, MD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 4112.

https://doi.org/10.1182/blood-2018-99-120130

Published: 2018

Journal Articles

Identification and Characterization of EBV Genome in NKT Cell Lymphoma

Yi Su, MD, Xi Yang, Hai Yi, MD, Fangyi Fan, Haoping Sun, Sihan Lai, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 5304.

https://doi.org/10.1182/blood-2018-99-118710

Published: 2018

Journal Articles

SLC2A5 Overexpression in Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukaemia

Pan Zhao, MD, Yuhuan Zheng, PhD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 5286.

https://doi.org/10.1182/blood-2018-99-118875

Published: 2018

Journal Articles

Chidamide-Containing Conditioning Allogenic Hematopoietic Stem Cell Transplantation Improves Prognosis of Acute Lymphoblastic Leukemia with Pre-Transplant Response Less Than Complete Remission

Jie Ji, MD, Tian Dong, MD PhD, Pu Kuang, MD PhD, Zhigang Liu, MD, Jiazhuo Liu, MD PhD, Li Zhang, MD, Ting Niu, MD PhD, Ting Liu, MD

Blood (2018) 132 (Supplement 1): 3366.

https://doi.org/10.1182/blood-2018-99-114763

Published: 2018

Journal Articles

A Potent Small Molecule Compound Might Overcome High Level Drug Resistant Mutations of Bcr-Abl1

Feng-Juan Wang, MD, Ting Niu, MD PhD

Blood (2016) 128 (22): 3942.

https://doi.org/10.1182/blood.V128.22.3942.3942

Published: 2016

Journal Articles

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Blood (2016) 128 (22): 4882.

https://doi.org/10.1182/blood.V128.22.4882.4882

Published: 2016

Journal Articles

4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass

Lung-Ji Chang, PhD, Lujia Dong, MD, Jun Zhu, MD, Zhitao Ying, MD, Hao-Hsian Kuo, MSc, Yuchen Liu, MSc, Yu-Qin Song, MD, Xiao-Pei Wang, MD, Yong-Qian Jia, MD, Ting Niu, MD PhD, Ting Liu, MDPhD, Ling Pan, MD, Zhuo-Gang Liu, MD, Tong Li, MD, Ying-Chun Li, MD, Kun Yao, MD, Xiaoyan Ke, MD PhD, Hongmei Jing, MD, Fang Bao, MD

Blood (2015) 126 (23): 264.

https://doi.org/10.1182/blood.V126.23.264.264

Published: 2015

Journal Articles

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Lujia Dong, MD, Lung-Ji Chang, PhD, Zhiyong Gao, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, MD, Jing-Bo Wang, MD, Le-Ping Zhang, MD, Yu-Hong Chen, MD, Hu-Yong Zheng, MD, Ting Liu, Ting Niu, MD PhD, He Huang, MD PhD, Rong Liu, MD, Heng-Xiang Wang, MD, Li Gao, MD, Tong-Hua Yang, MD, Xun Lai, MD

Blood (2015) 126 (23): 3774.

https://doi.org/10.1182/blood.V126.23.3774.3774

Published: 2015

Journal Articles

Rescue of a Terminally Ill Patient with Chemo-Refractory Acute Lymphoblastic Leukemia Carrying Bcr/Abl and TP53 Mutations Based on a 4th Generation CD19 Chimeric Antigen Receptor-Engineered T (CAR-T) Therapy

Ting Niu, MD PhD, Lung-Ji Chang, PhD, Jinrong Yang, MD, Yuchen Liu, MSc, Lujia Dong, MD, Wei Wang, PhD, Ting Liu, MD

Blood (2015) 126 (23): 5431.

https://doi.org/10.1182/blood.V126.23.5431.5431

Published: 2015

Journal Articles

Construction of the Lentiviral and Electric Transfection Vectors Encoding Anti-Human CD30 or CD33 Chimeric Antigen Receptor (CAR) Gene and Respective Expression Injurkat Leukemia Cell Line

Ke Zeng, MD, Ting Niu, MD PhD

Blood (2014) 124 (21): 5950.

https://doi.org/10.1182/blood.V124.21.5950.5950

Published: 2014

Journal Articles

Clinical Research on Hematological Malignancies Complicated with dic-a Single Center Report in China

Qing Wei, Ting Niu, MD PhD

Blood (2014) 124 (21): 5062.

https://doi.org/10.1182/blood.V124.21.5062.5062

Published: 2014

Journal Articles

Clinical Research on Burkitt Lymphoma—a Single-Center Report in China

Meng Jiang, MD, Ting Niu, MD PhD

Blood (2014) 124 (21): 5461.

https://doi.org/10.1182/blood.V124.21.5461.5461

Published: 2014

Journal Articles

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

Renchi Yang, MD, Ming Hou, MD, Junmin Li, MD PhD, Jie Jin, MD, Meijuan Huang, MD, Ziqiang Yu, MD, Xiaojun Xu, Xiaohui Zhang, Xin Du, MD, Ting Niu, MD PhD, Xiaoyan Ke, MD PhD, Jianmin Wang, MD PhD, Jing Liu, MD, Jing Sun, MD, Yongqiang Zhao, MD& PhD, Hua Lu, MD, Haiyi Guo, MD, Belinda Hsu, Senior statistician

Blood (2014) 124 (21): 1464.

https://doi.org/10.1182/blood.V124.21.1464.1464

Published: 2014

Journal Articles

Clinical Research On Hematological Malignancies Complicated With Active Tuberculosis:A Single Center Experience In China

Ting Niu, MD, PhD, Jun Li, MD, Meng Jiang, MD, Yiming Yang, MD, Ting Liu, MD

Blood (2013) 122 (21): 5592.

https://doi.org/10.1182/blood.V122.21.5592.5592

Published: 2013

Journal Articles

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Ling Pan, MD, PhD, Meng Chen, Yongqian Jia, MD, PhD, Xu Cui, MD, Ting Niu, MD, PhD, Hong Chang, MD, PhD, Hongbing Ma, MD, Jianjun Li, MD, Yuping Gong, MD, PhD, Xinchuan Chen, MD, Ting Liu, MD, PhD

Blood (2013) 122 (21): 5001.

https://doi.org/10.1182/blood.V122.21.5001.5001

Published: 2013

NARROW

Daratumumab, Bortezomib, Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory (RR) Multiple Myeloma (MM): Pooled Subgroup Analysis of Lepus and Castor

Efficacy Analysis of Ruxolitinib in Treatment of 72 Patients with Myelofibrosis in a Chinese Institution

A Novel Hybrid Transplantation with Autologous Hematopoietic Stem Cells and Matched Unrelated Cord Blood Stem Cells Is Effecttive and Safe for Relapsed or Refractory Lymphoma: A Pilot Study

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

KMT2D Is a Haploinsufficient Tumor Suppressor in Acute Leukemia

Alox15b Gene Contributes to Lymphoma Tumorigenesis Via PI3K/AKT/mTOR Pathway Activation and Has a Synergistic Effect with Alox5 Gene

Identification and Characterization of EBV Genome in NKT Cell Lymphoma

SLC2A5 Overexpression in Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukaemia

Chidamide-Containing Conditioning Allogenic Hematopoietic Stem Cell Transplantation Improves Prognosis of Acute Lymphoblastic Leukemia with Pre-Transplant Response Less Than Complete Remission

A Potent Small Molecule Compound Might Overcome High Level Drug Resistant Mutations of Bcr-Abl1

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Rescue of a Terminally Ill Patient with Chemo-Refractory Acute Lymphoblastic Leukemia Carrying Bcr/Abl and TP53 Mutations Based on a 4th Generation CD19 Chimeric Antigen Receptor-Engineered T (CAR-T) Therapy

Construction of the Lentiviral and Electric Transfection Vectors Encoding Anti-Human CD30 or CD33 Chimeric Antigen Receptor (CAR) Gene and Respective Expression Injurkat Leukemia Cell Line

Clinical Research on Hematological Malignancies Complicated with dic-a Single Center Report in China

Clinical Research on Burkitt Lymphoma—a Single-Center Report in China

Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study

Clinical Research On Hematological Malignancies Complicated With Active Tuberculosis:A Single Center Experience In China

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only